782016001: Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Glycopyrronium- and neostigmine-containing product\Glycopyrronium and neostigmine only product\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Product containing neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium and neostigmine only product\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Medicinal product categorized by disposition (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection

\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing quaternary ammonium compound (product)\Glycopyrronium-containing product\...

\Glycopyrronium- and neostigmine-containing product\Glycopyrronium and neostigmine only product\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection

\Glycopyrronium-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection

\Product manufactured as parenteral dose form (product)\Glycopyrronium-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Product manufactured as parenteral dose form (product)\Product containing neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection

\Product containing autonomic agent (product)\Parasympathomimetic agent-containing product\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Glycopyrronium- and neostigmine-containing product\Glycopyrronium and neostigmine only product\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Product containing autonomic agent (product)\Parasympathomimetic agent-containing product\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Product containing autonomic agent (product)\Parasympathomimetic agent-containing product\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase (product)\Product containing neostigmine (medicinal product)\Product containing neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Product containing autonomic agent (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium and neostigmine only product\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Product containing autonomic agent (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium- and neostigmine-containing product\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection
\Product containing autonomic agent (product)\Product containing acetylcholine receptor antagonist (product)\Product containing muscarinic receptor antagonist (product)\Glycopyrronium-containing product\Glycopyrronium-containing product in parenteral dose form\Glycopyrronium- and neostigmine-containing product in parenteral dose form\Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)\Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3752320013 Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3752321012 Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3752322017 Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4322861000052112 läkemedel som endast innehåller exakt neostigminmetylsulfat 2,5 milligram/milliliter och exakt glykopyrrolat 500 mikrogram/milliliter i injektionsvätska sv Synonym (core metadata concept) Inactive Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)
4639521000052116 glykopyrrolat 500 mikrogram/milliliter och neostigminmetylsulfat 2,5 milligram/milliliter, injektionsvätska sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has manufactured dose form	Solution for injection	true	Inferred relationship	Some
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	har täljarvärde för koncentrationsstyrka	500	false	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Is a	Product containing only glycopyrronium and neostigmine in parenteral dose form (medicinal product form)	true	Inferred relationship	Some
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has basis of strength substance (attribute)	Glycopyrronium bromide	false	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	har nämnarvärde som visar koncentrationsstyrka	ett	false	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	räkning av bas i aktiv ingrediens	två	false	Inferred relationship	Some
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has concentration strength numerator unit	mcg	false	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has precise active ingredient	Glycopyrronium bromide	false	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has concentration strength denominator unit	mL	true	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	har nämnarvärde som visar koncentrationsstyrka	ett	false	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	har täljarvärde för koncentrationsstyrka	2,5	false	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has basis of strength substance (attribute)	Neostigmine methylsulfate	false	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has concentration strength numerator unit	mg	false	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has precise active ingredient	Neostigmine methylsulfate	false	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has precise active ingredient	Neostigmine methylsulfate	true	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has basis of strength substance (attribute)	Neostigmine methylsulfate	true	Inferred relationship	Some	2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has concentration strength numerator unit	mcg	true	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has precise active ingredient	Glycopyrronium bromide	true	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has basis of strength substance (attribute)	Glycopyrronium bromide	true	Inferred relationship	Some	1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	Has concentration strength numerator unit	mg	true	Inferred relationship	Some	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3752320013	Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3752321012	Glycopyrrolate 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3752322017	Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4322861000052112	läkemedel som endast innehåller exakt neostigminmetylsulfat 2,5 milligram/milliliter och exakt glykopyrrolat 500 mikrogram/milliliter i injektionsvätska	sv	Synonym (core metadata concept)	Inactive	Entire term case insensitive (core metadata concept)	SNOMED CT Sweden NRC maintained module (core metadata concept)
4639521000052116	glykopyrrolat 500 mikrogram/milliliter och neostigminmetylsulfat 2,5 milligram/milliliter, injektionsvätska	sv	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Sweden NRC maintained module (core metadata concept)